ライフサイエンスコーパス: equine

1 the development of anti-EHV-1 agents in the equine.

2 periodic outbreaks of disease in humans and equines.

3 CIV subtypes, the H3N8 and H3N2 viruses, of equine and avian origins, respectively.

4 ine influenza viruses (CIV) H3N8 and H3N2 of equine and avian origins, respectively.

5 view and biological characterization of H3N8 equine and canine influenza viruses using various experi

6 Although equine and canine viruses hardly replicated in the respi

7 ere numerous genetic differences between the equine and canine viruses, this variation did not result

8 to the bacterial surface and for survival in equine and human blood.

9 with regard to SzM sequences and binding of equine and human fibrinogens.

10 S. equi subsp. zooepidemicus isolates of equine and human origins were compared with regard to Sz

11 e sites are generally well-conserved between equine and human SAs, but ibuprofen binds to both SAs in

12 the highly contagious disease "strangles" in equines and zoonotic meningitis in human.

13 inked sialic acid motif (SA2,3Gal) in avian, equine, and canine species; the alpha2,6-linked sialic a

14 Rapid preparation of purified equine anti-Ebola F(ab')2 offers a potentially efficient

15 Highly purified equine anti-Ebola F(ab')2 showed strong cross-neutraliza

16 We produced purified equine antisera from horses hyperimmunized with EBOV vir

17 ALB/c mice were given up to 2 mg of purified equine antisera per animal, at 30 minutes, 1 or 2 days p

18 rease the possibility of serum sickness, the equine antisera was digested with pepsin to generate F(a

19 tential target of IgE-mediated reactivity to equine antivenom and a possible cause of the high incide

20 ty reactions during the first application of equine antivenom.

21 tope are associated with hypersensitivity to equine antivenoms.

22 at might be applied to automate detection of equine arrhythmias in equine clinical practice.

23 Equine arteritis virus (EAV) and porcine reproductive an

24 conserved in all known arteriviruses except equine arteritis virus (EAV) and wobbly possum disease v

25 Equine arteritis virus (EAV) has a global impact on the

26 Equine arteritis virus (EAV) is the causative agent of e

27 olecule and possible cell entry receptor for equine arteritis virus (EAV).

28 Severe equine asthma (sEA), which closely resembles human asthm

29 Equine athletes have a pattern of exercise which is anal

30 genes are the porcine mitochondrial ND2 and equine ATP 6-8 genes.

31 examined the potential of H3N8 from canine, equine, avian, and seal origin to productively infect pi

32 ulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine) (BAT) manufactured by Emergent BioSolutions Cana

33 he gel coating reduced the immunogenicity of equine BChE, unlocking the possibility to use non-human

34 Understanding equine behaviour and cognition can inform horse welfare

35 The equine beta-defensins (eBDs) eBD1, -2, and -3 were produ

36 bacteria, EHV1 resisted potent antimicrobial equine beta-defensins (eBDs) eBD2 and eBD3 by the action

37 ection of H. capsulatum var. farciminosum in equine blood and at high frequency among horses exhibiti

38 Equine BMNC cultured in autologous SF or ISF (n = 8 hors

39 iry manure slurry and a dry stack mixture of equine, bovine, and ovine manure.

40 th four H3N8 viruses from different origins (equine, canine, avian, and seal) were performed.

41 In horses, the CXCL16 gene is located on equine chromosome 11 (ECA11) and encodes a glycosylated,

42 automate detection of equine arrhythmias in equine clinical practice.

43 rRNA operon was validated for application to equine clinical samples.

44 this study, we evaluated the ability of the equine clinical treatments N-acetylcysteine, EDTA, and h

45 st report on mitochondrial efficiency in the equine COC and provide new insight into comparative game

46 Up to 38% of equine COC oxygen consumption could be attributed to non

47 ling to satisfy the metabolic demands of the equine COC.

48 s immunocompromised; both patients had known equine contact.

49 on cold), human enteric coronavirus (HECoV), equine coronavirus (ECoV), and equine torovirus Berne (B

50 y metabolism and mitochondrial efficiency in equine cumulus-oocyte complexes (COCs) during in vitro m

51 us studies in our laboratory have identified equine CXCL16 (EqCXCL16) to be a candidate molecule and

52 ic killer of equine neutrophils and identify equine-CXCRA and CXCR2 as its target receptors.

53 iation/association kinetics for yeast versus equine cytochrome c indicate that formation of mammalian

54 ides generated by enzymatic digestion of the equine cytochrome c with trypsin.

55 in variants, such as bovine cytochrome c and equine cytochrome c, which differ by only three amino ac

56 inical and regulatory development to replace equine DAT.

57 n result in 10,000 s of human cases and mass equine death.

58 per day, intravenously, on days -4 to -2, or equine derived 30 mg/kg per day, intravenously, on days

59 Equine-derived heptavalent botulinum antitoxin (HBAT), t

60 ed by Emergent BioSolutions Canada Inc is an equine-derived heptavalent botulinum antitoxin product i

61 Despeciated, equine-derived, heptavalent botulinum antitoxin (HBAT) i

62 e for association studies of immune-mediated equine diseases and for evolutionary analysis of genetic

63 Equine early pregnancy loss (EPL) has no diagnosis in ov

64 The analysis of equine electrocardiographic (ECG) recordings is complica

65 In contrast, equine embryonic stem cell (ESC) derived tenocytes expos

66 urements of multi-metabolites of single-cell equine embryos for assisted reproduction technologies.

67 for small biological samples such as single equine embryos.

68 nonstructural proteins (nsPs) of Venezuelan equine encephalitis (VEE) replicon that promoted subgeno

69 Eastern equine encephalitis diagnostic serum antibody can appear

70 is, western equine encephalitis, and eastern equine encephalitis expressing the surface proteins of a

71 Zika virus or Ebola, Chikungunya, or eastern equine encephalitis pseudoviruses was inhibited with gre

72 oly I:C) and a potential vaccine [Venezuelan equine encephalitis replicon particles expressing MERS-C

73 , or an unrelated, intramuscular, Venezuelan equine encephalitis replicon vaccine expressing EBOV GP.

74 EBOV glycoprotein (GP)-expressing Venezuelan equine encephalitis viral replicon particle vaccine prot

75 Eastern equine encephalitis virus (EEEV) infection was identifie

76 Eastern equine encephalitis virus (EEEV) is a mosquito-transmitt

77 Eastern equine encephalitis virus (EEEV) is a representative mem

78 ghly pathogenic phenotype.IMPORTANCE Eastern equine encephalitis virus (EEEV) is one of the most path

79 Eastern equine encephalitis virus (EEEV) is one of the most viru

80 Eastern equine encephalitis virus (EEEV) is the most pathogenic

81 Eastern equine encephalitis virus (EEEV), a mosquito-borne icosa

82 an equine encephalitis virus (VEEV), eastern equine encephalitis virus (EEEV), and western equine enc

83 equine encephalitis virus (VEEV) and Eastern equine encephalitis virus (EEEV), which have demonstrate

84 quine encephalitis virus (WEEV), and eastern equine encephalitis virus (EEEV).

85 are the encephalitic alphaviruses Venezuelan equine encephalitis virus (VEEV) and Eastern equine ence

86 her related alphaviruses, such as Venezuelan equine encephalitis virus (VEEV) and Semliki Forest viru

87 New attenuated variants of Venezuelan equine encephalitis virus (VEEV) designed in this study

88 Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne RNA

89 Venezuelan equine encephalitis virus (VEEV) is a neurotropic alphav

90 Venezuelan equine encephalitis virus (VEEV) is a New World Alphavir

91 Venezuelan equine encephalitis virus (VEEV) is a previously weaponi

92 Venezuelan equine encephalitis virus (VEEV) is a select agent that

93 Venezuelan equine encephalitis virus (VEEV) is an alphavirus that i

94 Venezuelan equine encephalitis virus (VEEV) is an alphavirus with a

95 Venezuelan equine encephalitis virus (VEEV) is an emerging pathogen

96 Venezuelan equine encephalitis virus (VEEV) is an important human a

97 Venezuelan equine encephalitis virus (VEEV) is an important human a

98 Venezuelan equine encephalitis virus (VEEV) is one of the important

99 The infectious titer of WNV and Venezuelan equine encephalitis virus (VEEV) TC83 in the brains of A

100 Finally, mice infected with Venezuelan equine encephalitis virus (VEEV) were successfully treat

101 Murine infection with wild-type Venezuelan equine encephalitis virus (VEEV), a highly myeloid-cell-

102 Venezuelan equine encephalitis virus (VEEV), a New World alphavirus

103 The structures of human Venezuelan equine encephalitis virus (VEEV), an alphavirus, in comp

104 ins drive the assembly of vRCs of Venezuelan equine encephalitis virus (VEEV), and G3BPs were shown t

105 , Rift Valley fever virus (RVFV), Venezuelan equine encephalitis virus (VEEV), and herpes simplex vir

106 The alphaviruses Venezuelan equine encephalitis virus (VEEV), eastern equine encepha

107 IMPORTANCE RNA viruses, including Venezuelan equine encephalitis virus (VEEV), have high mutation rat

108 se severe encephalitis in humans: Venezuelan equine encephalitis virus (VEEV), western equine encepha

109 eat infection with the alphavirus Venezuelan equine encephalitis virus (VEEV), which causes flu-like

110 ics are currently unavailable for Venezuelan equine encephalitis virus (VEEV), which elicits flu-like

111 vel of heterologous proteins from Venezuelan equine encephalitis virus (VEEV)-based replicons.

112 emonstrate that Tc bovine-derived Venezuelan equine encephalitis virus (VEEV)-specific TcPAbs are hig

113 quine encephalitis virus (EEEV), and western equine encephalitis virus (WEEV) are arthropod-borne pos

114 Western equine encephalitis virus (WEEV) has caused several epid

115 Western equine encephalitis virus (WEEV) is an arbovirus from th

116 an equine encephalitis virus (VEEV), western equine encephalitis virus (WEEV), and eastern equine enc

117 o pathogenic mosquito-borne viruses (Eastern equine encephalitis virus [EEEV], Western equine encepha

118 equine encephalitis virus [WEEV], Venezuelan equine encephalitis virus [VEEV], and Chikungunya virus

119 rn equine encephalitis virus [EEEV], Western equine encephalitis virus [WEEV], Venezuelan equine ence

120 r atomic resolution structures of Venezuelan equine encephalitis virus and dengue virus revealed tran

121 inhibitors of the replication of Venezuelan equine encephalitis virus and other alphaviruses.

122 er encephalitic arboviruses, such as eastern equine encephalitis virus and West Nile virus, underscor

123 very amino-terminal subdomain of Venezuelan equine encephalitis virus capsid protein, SD1, plays a c

124 IXV) is an enzootic member of the Venezuelan Equine Encephalitis Virus complex and belongs to the New

125 iruses including West Nile virus and Eastern equine encephalitis virus has been detected in wild Atla

126 ase manifestations characteristic of eastern equine encephalitis virus infection in humans.

127 a virus-vectored vaccine (Kp47/47-Venezuelan equine encephalitis virus replicon particle) for safety,

128 s of >100 in cell-based assays using western equine encephalitis virus replicons.

129 pagating, truncated derivative of Venezuelan equine encephalitis virus that targets dendritic cells (

130 n coronavirus 229E), Togaviridae (Venezuelan equine encephalitis virus), and Hepeviridae (HEV), indic

131 nly one other NT human arbovirus (Venezuelan equine encephalitis virus), which is also poorly underst

132 ing primary mosquito infection by Venezuelan equine encephalitis virus, an arbovirus causing neurolog

133 lethal alphavirus infection with Venezuelan equine encephalitis virus, and this was associated with

134 he alphaviruses Sindbis virus and Venezuelan equine encephalitis virus, as well as La Crosse bunyavir

135 e virus, Jamestown Canyon virus, and eastern equine encephalitis virus, as well as the tick-borne Pow

136 ellow fever virus, Sindbis virus, Venezuelan equine encephalitis virus, measles virus, influenza A vi

137 specific partners of nsP3 HVD of Venezuelan equine encephalitis virus.

138 Venezuelan and western equine encephalitis viruses (VEEV and WEEV; Alphavirus;

139 bis, Chikungunya, and eastern and Venezuelan equine encephalitis viruses and demonstrate that a small

140 halitic alphaviruses (eastern and Venezuelan equine encephalitis viruses) based upon either fusion of

141 for Venezuelan equine encephalitis, western equine encephalitis, and eastern equine encephalitis exp

142 ause Venezuelan equine encephalitis, western equine encephalitis, and eastern equine encephalitis.

143 seen with Japanese encephalitis, Venezuelan equine encephalitis, and Rift Valley fever viruses; and

144 and viruses (West Nile, Eastern and Western Equine Encephalitis, St.

145 developed a combined vaccine for Venezuelan equine encephalitis, western equine encephalitis, and ea

146 lenge with the viruses that cause Venezuelan equine encephalitis, western equine encephalitis, and ea

147 is, western equine encephalitis, and eastern equine encephalitis.

148 S), previously unreported reoviruses such as equine encephalosis virus, Wad Medani virus (WMV), Kamma

149 To characterize the role of biofilms in equine endometritis, six mares were inoculated with lux-

150 present during clinical cases of infectious equine endometritis.

151 a interferon (IFN-beta) response in vitro in equine endothelial cells (EECs) at 12 h postinfection (h

152 ion followed by a rapid shutdown in vitro in equine endothelial cells (EECs).

153 n content and organisation, in young and old equine energy storing and positional tendons.

154 to characterise aneuploidies associated with equine EPL.

155 vidence of aneuploidy in naturally occurring equine EPLs at a similar rate to human miscarriage.

156 prior hysterectomy received oral conjugated equine estrogen (0.625 mg/day) or placebo.

157 ndomized to receive 0.625 mg/d of conjugated equine estrogen (CEE) plus 2.5 mg/d of medroxyprogestero

158 with a uterus were randomized to conjugated equine estrogens (0.625 mg/d [estrogen]) plus medroxypro

159 Conjugated equine estrogens (CEE) (0.625 mg/d) or placebo for a med

160 ociations between the use of oral conjugated equine estrogens (CEE) (0.625 mg/day) plus medroxyproges

161 trolled hormone therapy trials of conjugated equine estrogens (CEE) among posthysterectomy participan

162 heart disease (CHD), whereas oral conjugated equine estrogens (CEE) did not.

163 Conjugated equine estrogens (CEE, 0.625 mg/d) plus medroxyprogester

164 to receive 4 y of 0.45 mg/d oral conjugated equine estrogens (o-CEE) plus 200 mg/d micronized proges

165 r hysterectomy were randomized to conjugated equine estrogens alone (0.625 mg/d) or placebo with a me

166 one Therapy), treatment with oral conjugated equine estrogens and medroxyprogesterone acetate (CEE+MP

167 usal women over 60 who are taking conjugated equine estrogens and the beneficial effect of low-dose e

168 one, replication was not observed in primary equine fetal liver cultures or after electroporation of

169 neurological disease and death in humans and equines following transmission from infected mosquitoes.

170 Although the equine fossil record represents a textbook example of ev

171 V from different lineages and sublineages, A/equine/Georgia/1/1981 (eq/GA/81) was selected to produce

172 he complex collagen architecture of juvenile equine growth cartilage.

173 enetic analysis indicated that the X-ORFs of equine H3N8 and avian H3N2 influenza viruses encoded 61

174 s for use in the event of transmission of an equine H3N8 influenza virus to humans.

175 netic analysis showed that the PA-X genes of equine H3N8 or avian H3N2 influenza viruses were full-le

176 pandemic virus and, independently, the 1963 equine H3N8 panzootic lineage.

177 igosaccharide cellopentaose, and the protein equine heart cytochrome c.

178 Equine hepacivirus (EHCV; nonprimate hepacivirus) is a h

179 e many animal and primate hepaciviruses, the equine hepaciviruses remain the closest genetic relative

180 the SRT of IE62 was replaced with the SRT of equine herpesvirus 1 (EHV-1) IEP, its trans-activation a

181 accination remains the best option to combat equine herpesvirus 1 (EHV-1) infection, and several diff

182 Equine herpesvirus 1 (EHV-1) is a major pathogen affecti

183 s virus to and from T lymphocytes.IMPORTANCE Equine herpesvirus 1 (EHV1) is an ancestral alphaherpesv

184 Equine herpesvirus 1 (EHV1) replicates in the respirator

185 e most severe disease outcomes, abortion and equine herpesvirus myeloencephalopathy (EHM).

186 Equine herpesvirus type 1 (EHV-1) outbreaks continue to

187 ORF2 as a vaccine candidate.IMPORTANCE Nasal equine herpesvirus type 1 (EHV-1) shedding is essential

188 We used the alphaherpesvirus equine herpesvirus type 1 (EHV1) and equine respiratory

189 Equine herpesvirus type 1 (EHV1), a well-known member of

190 demonstrate how a central alphaherpesvirus, equine herpesvirus type 1 (EHV1), actually exploits beta

191 host-specific and ancestral alphaherpesvirus equine herpesvirus type 1 (EHV1).

192 multiple introductions of MRSA CC398 in a UK Equine Hospital, identifying an emerging zoonotic pathog

193 -hemolytic Streptococcus dysgalactiae in the equine host is increasingly recognized.

194 simultaneous detection of allergen-specific equine IgE in serum against a wide range of putative all

195 Such equine IgG may find utility as a post-exposure prophylac

196 Herein we describe production of purified equine IgG obtained from horses immunized with plasmid D

197 Administration of the equine IgG over 5 days to cynomolgus macaques infected 2

198 and developed a therapeutic vaccine against equine IL-31 (eIL-31).

199 The vaccine consisted of equine IL-5 (eIL-5) covalently linked to a cucumber mosa

200 We aimed to dissect equine immune responses after experimental NPHV infectio

201 Following viral challenge, an activation of equine immune responses was observed.

202 clear cells modulate joint homeostasis in an equine in vivo model of synovitis.

203 ritis virus (EAV) has a global impact on the equine industry as the causative agent of equine viral a

204 source of significant economic loss for the equine industry from high rates of abortion in pregnant

205 mportant due to major economic losses in the equine industry.

206 The lentivirus equine infectious anemia virus (EIAV) encodes the small

207 rine leukemia virus (MLV), the S2 protein of equine infectious anemia virus (EIAV), and the Nef prote

208 tibody escape data from horses infected with equine infectious anemia virus.

209 humans; however, a recent report showed that equine influenza A viruses (IAVs) can be isolated from p

210 ne influenza virus (CIV) emerged from A/H3N8 equine influenza virus (EIV) around the year 2000 throug

211 H3N8 originated from a direct transfer of an equine influenza virus (EIV) in the early 2000s.

212 V; H3N8) originated after the transfer of an equine influenza virus (EIV) into dogs.

213 , which originated from the transfer of H3N8 equine influenza virus to dogs; and the H3N2 CIV, which

214 04 an hemagglutinin 3 neuraminidase 8 (H3N8) equine influenza virus was transmitted from horses to do

215 Equine influenza viruses (EIV) are responsible for rapid

216 ibution of K186 and E186 among H3N8 CIVs and equine influenza viruses (EIVs), the ancestors of H3N8 C

217 Equine influenza viruses have crossed the species barrie

218 it is important to develop vaccines against equine influenza viruses in the event that an EIV evolve

219 and 16S rRNA gene sequence showed that most equine isolates could also be differentiated from S. dys

220 other antimicrobial agents against clinical equine isolates of Corynebacterium pseudotuberculosis.

221 lciforme strains (12/15) were recovered from equine keratitis infections; however, strains of F. kera

222 est the potential anti-rotavirus activity of equine lactadherin and support the feasibility of develo

223 In equine macrophages, the macrolide-resistant strain did n

224 We observed that equine MaSCs (eMaSCs) maintain their growth potential in

225 cosal, 65 primary canine oral and 28 primary equine melanoma cases from mucosal sites.

226 s with prominent pigment synthesis mimicking equine melanoma represent a rare variant of biologically

227 ing (SAXS) was used to study the behavior of equine metmyoglobin (Mb) and bovine pancreatic trypsin i

228 .e., bovine pancreatic trypsin inhibitor and equine metmyoglobin, on the conformational ensemble of a

229 equine regional dermal asthenia (HERDA), an equine model of Ehlers-Danlos syndromes.

230 An in vivo equine model of infectious endometritis was also develop

231 Using an equine model of late development, we report the first ph

232 EAV entry receptor in EAV-susceptible cells, equine monocytes.

233 (EFA) was applied to small groups of bovine, equine, mouse and human oocytes and bovine early embryos

234 nd mainly in North America, causes human and equine neurotropic infections.

235 hat LukPQ is a potent and specific killer of equine neutrophils and identify equine-CXCRA and CXCR2 a

236 The closest homolog of HCV is the equine nonprimate hepacivirus (NPHV), which shares simil

237 r with rabies immunoglobulin (RIG) of either equine or human origin.

238 ne influenza virus (CIV) H3N2 (CIV-H3N2) and equine-origin CIV H3N8 (CIV-H3N8), are enzootic in the c

239 Equine-origin H3N8 and avian-origin H3N2 canine influenz

240 enza viruses to dogs.IMPORTANCE Epidemics of equine-origin H3N8 and avian-origin H3N2 influenza virus

241 respiratory disease in dogs, and include the equine-origin H3N8 and the avian-origin H3N2 viruses.

242 s encoding 61 amino acids; however, those of equine-origin H3N8 or avian-origin H3N2 CIVs were trunca

243 tion, utilizing bioluminescence imaging with equine P. aeruginosa isolates from this study.

244 n, using a convolutional neural network (ii) equine papillomavirus 2 (EcPV2) infection, detected usin

245 Experience with formulating guidelines for equine parasite control illustrates that end-users strug

246 ge of the vector ecology of these tick-borne equine pathogens, emphasizing tick transmissibility and

247 h most of these animals were coinfected with equine pegivirus (EPgV), also a flavivirus, EPgV viral l

248 Equine penile squamous cell carcinoma (EpSCC) is a relat

249 Stabilized, acellular, equine pericardial collagen matrix (sPCM) wound care dre

250 Equine piroplasmosis is a disease of Equidae, including

251 he in silico-predicted recognition motif for equine PR/SET domain 9 (PRDM9) in recombination hotspots

252 ends decades of speculation, explaining how equine pregnancies survive without measurable circulatin

253 physiological concentrations and to maintain equine pregnancy in the absence of luteal progesterone i

254 justify future efficacy studies for purified equine products in NHPs.

255 e on intracellular replication of R. equi in equine pulmonary macrophages and in an in vivo mouse inf

256 oc mobilization from a direct predecessor of equine pVAPA.

257 circular virulence plasmids associated with equine (pVAPA) and porcine (pVAPB variant) R. equi isola

258 lance was implemented from 2011-2016 in a UK Equine Referral Veterinary Hospital and identified 81 me

259 f myodural bridges in horses with hereditary equine regional dermal asthenia (HERDA), an equine model

260 roxide to disrupt in vitro biofilms and kill equine reproductive pathogens (Escherichia coli, Pseudom

261 Pretreatment of primary equine respiratory epithelial cells (EREC) with eBD1, -2

262 ine respiratory mucosal explants and primary equine respiratory epithelial cells (EREC), grown at the

263 ratory mucosal explants and in vitro primary equine respiratory epithelial cells (EREC).

264 alphaherpesvirus family, was used to infect equine respiratory mucosal explants and primary equine r

265 ing specific nucleic acid sequences for four equine respiratory pathogens as representative examples,

266 esvirus equine herpesvirus type 1 (EHV1) and equine respiratory tissues to decipher this key event in

267 We demonstrate that the closely related equine rhinitis A virus (ERAV) L(pro) also cleaves G3BP1

268 cryo-electron microscopy structure of native equine rhinitis A virus (ERAV), together with the struct

269 ure of a unique, massively expanded state of equine rhinitis A virus that provides insight into how t

270 . zooepidemicus isolates but much less so in equine S. equi subsp. zooepidemicus isolates.

271 We also compare the binding of ketoprofen by equine SA to binding of it by bovine and leporine SAs.

272 1 to the inhibitory effect of both human and equine SERINC5.

273 The binding modes to equine serum albumin (ESA) of two nonsteroidal anti-infl

274 We report the crystal structures of equine serum albumin complexed with four NSAIDs (ibuprof

275 man erythrocyte acetylcholinesterase (AChE), equine serum butyrylcholinesterase (BChE), and a structu

276 -circulating bioscavenger nanogel by coating equine serum-derived BChE with a zwitterionic polymer ge

277 d 378 Arabian horses from 12 countries using equine single nucleotide polymorphism (SNP) arrays and w

278 further, we hypothesized that an equivalent equine SOD1 variant would share similar perturbations in

279 e for gene flow involving three contemporary equine species despite chromosomal numbers varying from

280 vidual, woolly mammoths, polar bears and two equine species, we confirm that DNA methylation survives

281 Even though the equine sport industry has considerable economic value to

282 ring tendons, such as the human Achilles and equine superficial digital flexor tendon (SDFT), are hig

283 oidies have never been reported in live born equines, supporting their embryonic/fetal lethality.

284 ference point for the complexity analysis of equine telemetric ECG recordings that might be applied t

285 es, and to investigate the role of HA in the equine to canine cross-species transfer, we used X-ray c

286 irus (HECoV), equine coronavirus (ECoV), and equine torovirus Berne (BEV) are enzymatically active, r

287 y for the homologous protein of a torovirus, equine torovirus, which is more closely related to coron

288 Pseudomonas aeruginosa strains isolated from equine uterine infections.

289 hat Gram-negative bacteria isolated from the equine uterus are capable of producing a biofilm in vitr

290 for elimination of bacterial biofilm in the equine uterus.

291 gle nonantibiotic treatment commonly used in equine veterinary practice was able to reduce the CFU an

292 eritis virus (EAV) is the causative agent of equine viral arteritis (EVA), a reproductive and respira

293 he equine industry as the causative agent of equine viral arteritis (EVA), a respiratory, systemic, a

294 ic reasoning, using a simulation game named "Equine Virtual Farm" (EVF).

295 In the fusion subdomain of canine and recent equine virus HAs a unique difference is observed by comp

296 s of the HAs from two antigenically distinct equine viruses and from a canine virus.

297 antiviral activity of lactadherin sourced by equines, we undertook a proteomic analysis of milk fat g

298 -1 strain KyA is attenuated in the mouse and equine, whereas wild-type strain RacL11 induces severe i

299 irus 1 (EHV-1) is a major pathogen affecting equines worldwide.

300 robial and metabolic profiles of a cohort of equine youngstock, prior to and following treatment with